PaullJ.Clinical report of the use of sodium nitroprusside in severe pre-eclampsia. Anaesth Intens Care1975; 3: 72.
6.
StempelJ.E., O'GradyJ.P., MortonM.J., JohnsonK.A.Use of sodium nitroprusside in complications of gestational hypertension. Obstet Gynecol1982; 60: 533–538.
7.
GoodlinR.C.Safety of sodium nitroprusside. Obstet Gynecol1983; 62: 270.
8.
ShoemakerC.T., MeyersM.Sodium nitroprusside for control of severe hypertensive disease of pregnancy: a case report and discussion of potential toxicity. Am J Obstet Gynecol1984; 149: 171–173.
9.
DunningP.C., BurgerP duT. Fetal abnormality associated with the use of captopril during pregnancy. South African Med J1981; 60: 805.
10.
Broughton-PipkinF., SymondsE.M., TurnerS.R.The effect of captopril upon mother and fetus in the chronically cannulated ewe and in the pregnant rabbit. J Physiol1982; 323: 415–422.
11.
RubinP.C.Beta blockers in pregnancy. N Engl J M1981; 305: 1323–1326.
12.
ChervenakF.A., BerkowitzR.L.Hypertension in pregnancy. Mount Sinai J Med1985; 52: 46–57.
13.
WaltersB.N.J., RedmanC.W.G.Treatment of severe pregnancy associated hypertension with the calcium antagonist nifedipine. Br J Obstet Gynaecol1984; 91: 330–36.
14.
MabieW.C., GonzalezA.R., SibaiB.M., AmonE.A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol1987; 70: 328–33.
15.
CottonD.B., GonikB., DormanK.P.Cardiovascular alterations in severe pregnancy — induced hypertension: acute effects of intravenous magnesium sulfate. Am J Obstet Gynecol1984; 148: 162–5.
16.
LeeM.I., ToddH.M., BoweA.The effects of magnesium sulfate infusion on blood pressure and vascular responsiveness during pregnancy. Am J Obstet Gynecol1984; 149: 705–8.
17.
RubinP.C.Treatment of hypertension in pregnancy. Clinics in Obstetrics and Gynecology1986; 13: 307–317.
18.
JoyceT.H., DebnathK.S., BakerE.A.Pre-eclampsia — relationship of CVP and epidural analgesia. Anesthesiology1979; 181: S297.
19.
GalleryE.D.M., HunyorS.N., GyöryA.Z.Plasma volume contraction: a significant factor in both pregnancy-associated hypertension (pre-eclampsia); and chronic hypertension in pregnancy. Quart J Med NS1979; 48: 593–602.
20.
GalleryE.D.M., DelpradoW., GyöryA.Z.Antihypertensive effect of plasma volume expansion in pregnancy-associated hypertension. Aust NZ J Med1981; 11: 20–24.
21.
NaultyJ., CefaloR.C., LewisP.E.Fetal toxicity of nitroprusside in the pregnant ewe. Am J Obstet Gynecol1981; 139: 708–711.
22.
MerrifieldA., BlundellM.Toxicity of sodium nitroprusside. Br J Anaesth1974; 46: 324–326.
EllisS.C., WheelerA.S., JamesFMIIIFetal and maternal effects of sodium nitroprusside used to counteract hypertension in gravid ewes. Am J Obstet Gynecol1982; 143: 766–770.
25.
CottonD.B., LongmireS., JonesM.M., DormanK.R., TessemJ., JoyceTHIII. Cardiovascular alterations in severe pregnancy — induced hypertension: Effects of intravenous nitroglycerin compared with blood volume expansion. Am J Obstet Gynecol1986; 154: 1053–1059.